Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001096906-21-002676

← back to feed
Filed
Nov 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · Nov 12, 2021 207.9M sh
Capex Q1 2022 · Sep 30, 2021 $0
Capex Q1 2022 · Sep 30, 2020 $0
Short Term Debt Q1 2022 · Sep 30, 2021 $745.6K
Short Term Debt Q1 2022 · Jun 30, 2021 $752.51K
Stockholders Equity Q1 2022 · Sep 30, 2021 −$239.06K
Stockholders Equity Q1 2022 · Jun 30, 2021 −$223.53K
Current Liabilities Q1 2022 · Sep 30, 2021 $968.23K
Current Liabilities Q1 2022 · Jun 30, 2021 $954.71K
Total Liabilities Q1 2022 · Sep 30, 2021 $1.03M
Total Liabilities Q1 2022 · Jun 30, 2021 $1.01M
Current Assets Q1 2022 · Sep 30, 2021 $49.23K
Current Assets Q1 2022 · Jun 30, 2021 $66.67K
Total Assets Q1 2022 · Sep 30, 2021 $134.8K
Total Assets Q1 2022 · Jun 30, 2021 $134.12K
Operating Cash Flow Q1 2022 · Sep 30, 2020 −$29.52K
Cash And Equivalents Q1 2022 · Sep 30, 2020 $21.13K
Cash And Equivalents Q1 2022 · Jun 30, 2020 $15.28K
Sga Expense Q1 2022 · Sep 30, 2020 $11.75K
Rd Expense Q1 2022 · Sep 30, 2020 $2.43K
Net Income Q1 2022 · Sep 30, 2020 −$74.89K
Operating Income Q1 2022 · Sep 30, 2020 −$44.41K
Gross Profit Q1 2022 · Sep 30, 2020 $19.88K
Revenue Q1 2022 · Sep 30, 2020 $19.88K